The Control of Gene Expression by Eukaryotic Ribonucleases

真核核糖核酸酶对基因表达的控制

基本信息

项目摘要

Project Summary/Abstract RNA degradation plays multiple essential functions in the control of gene expression. It not only regulates global transcript abundance, but also provides quality control mechanisms to eliminate improperly processed or mis-localized transcripts, or those containing premature translation termination codons (PTCs). Work in our laboratory focuses on two major RNA degradation pathways in eukaryotic cells: Nonsense- Mediated Decay (NMD), which degrades PTC-containing transcripts, and the Exosome, which processes a variety of non-coding RNAs and also degrades transcripts during quality-control processes. A combination of genomic approaches and classical genetic and biochemical analyses has allowed us to identify new roles for these pathways in gene regulation, including proofreading of splice site selection, regulation of specific mRNAs and the mechanisms underlying distinct modes of Pol.II termination. We have also identified the molecular consequences of clinical mutations in exosome subunits implicated in pontocerebellar hypoplasia (PCH). The work proposed in this application will broadly expand our understanding of the role of the subunits of the exosome and of its associated factors on RNA processing and degradation genome-wide. In addition, we will determine how the activity of the exosome is controlled during stress, and how it cooperates with other RNA quality control pathways such as those coupled to translation. Finally we will characterize the mechanisms that promote 3´-end formation for a novel class of mRNAs, which use a mechanism completely independent from the classical cleavage and polyadenylation pathway. Overall, the proposed studies will provide major advances in our understanding of the mechanisms involved in eukaryotic post-transcriptional regulations and RNA processing.
项目摘要/摘要 RNA降解在基因表达调控中起着多种重要作用。它 不仅调节全球转录丰度,还提供质量控制 消除未正确处理或错误本地化的记录的机制,或 含有提前翻译终止密码子(PTCs)。在我们的实验室工作 聚焦于真核细胞中两个主要的RNA降解途径:胡说八道- 介导的衰变(NMD),它降解含有PTC的转录本,以及Exosome, 它处理各种非编码RNA,并在 质量控制流程。基因组学方法和经典遗传学的结合 生化分析使我们能够确定这些途径在 基因调控,包括剪接位点选择的校对、特异性的调控 MRNAs和Pol.II不同终止模式的潜在机制。我们有 还确定了临床上外切体亚单位突变的分子后果 与桥小脑发育不全(PCH)有关。本申请中提出的工作 将广泛地扩展我们对外体亚单位作用的理解 其在全基因组范围内对RNA加工和降解的相关因素。此外,我们 将决定应激期间外切体的活动是如何被控制的,以及它是如何 与其他RNA质量控制途径合作,例如耦合到 翻译。最后,我们将描述促进3‘端形成的机制 对于一类新的mRNAs,它使用一种完全独立于 经典的切割和多聚腺苷酸化途径。整体而言,拟议的研究将会 为我们理解真核生物所涉及的机制提供重大进展 转录后调控和RNA加工。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protocol for High-Resolution Mapping of Splicing Products and Isoforms by RT-PCR Using Fluorescently Labeled Primers.
  • DOI:
    10.1016/j.xpro.2020.100140
  • 发表时间:
    2020-12-18
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Weathers I;Gabunilas J;Samson J;Roy K;Chanfreau GF
  • 通讯作者:
    Chanfreau GF
Functional Analysis of the Zinc Finger Modules of the S. cerevisiae Splicing Factor Luc7.
酿酒酵母剪接因子 Luc7 的锌指模块的功能分析。
  • DOI:
    10.1101/2024.02.04.578419
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Carrocci,TuckerJ;DeMario,Samuel;He,Kevin;Zeps,NatalieJ;Harkner,CadeT;Chanfreau,Guillaume;Hoskins,AaronA
  • 通讯作者:
    Hoskins,AaronA
Robust mapping of polyadenylated and non-polyadenylated RNA 3' ends at nucleotide resolution by 3'-end sequencing.
通过 3 末端测序,以核苷酸分辨率对聚腺苷酸化和非聚腺苷酸化 RNA 3 末端进行稳健定位。
  • DOI:
    10.1016/j.ymeth.2019.05.016
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Roy,KevinR;Chanfreau,GuillaumeF
  • 通讯作者:
    Chanfreau,GuillaumeF
Nanoblot: an R-package for visualization of RNA isoforms from long-read RNA-sequencing data.
  • DOI:
    10.1261/rna.079505.122
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    DeMario, Samuel;Xu, Kevin;He, Kevin;Chanfreau, Guillaume F
  • 通讯作者:
    Chanfreau, Guillaume F
Stress-induced inhibition of mRNA export triggers RNase III-mediated decay of the BDF2 mRNA.
  • DOI:
    10.1261/rna.078880.121
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wang C;Barr K;Neutel D;Roy K;Liu Y;Chanfreau GF
  • 通讯作者:
    Chanfreau GF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guillaume F Chanfreau其他文献

Guillaume F Chanfreau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guillaume F Chanfreau', 18)}}的其他基金

The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    10318112
  • 财政年份:
    2019
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    10078951
  • 财政年份:
    2019
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic RNase III
真核RNase III对基因表达的控制
  • 批准号:
    7904443
  • 财政年份:
    2009
  • 资助金额:
    $ 39.46万
  • 项目类别:
THE CONTROL OF GENE EXPRESSION BY EUKARYOTIC RNASE III
真核RNA酶III对基因表达的控制
  • 批准号:
    6387187
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
THE CONTROL OF GENE EXPRESSION BY EUKARYOTIC RNASE III
真核RNA酶III对基因表达的控制
  • 批准号:
    6157661
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    7988151
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    8294661
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
THE CONTROL OF GENE EXPRESSION BY EUKARYOTIC RNASE III
真核RNA酶III对基因表达的控制
  • 批准号:
    6763207
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    9304241
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:
The Control of Gene Expression by Eukaryotic Ribonucleases
真核核糖核酸酶对基因表达的控制
  • 批准号:
    9085299
  • 财政年份:
    2000
  • 资助金额:
    $ 39.46万
  • 项目类别:

相似海外基金

Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial
慢性肾病患者便秘治疗的临床、生化和微生物学效果:初步可行性试验
  • 批准号:
    10639532
  • 财政年份:
    2023
  • 资助金额:
    $ 39.46万
  • 项目类别:
Biochemical and psycholigical verfication of cancer pain relief by aromatherapy and clinical application to nursing support
芳香疗法缓解癌症疼痛的生化和心理验证及其护理支持的临床应用
  • 批准号:
    20K19081
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clinical, Radiologic and Biochemical Factors Related to Diabetes Development after Acute Pancreatitis
急性胰腺炎后与糖尿病发展相关的临床、放射学和生化因素
  • 批准号:
    10458035
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
Clinical, Radiologic and Biochemical Factors Related to Diabetes Development after Acute Pancreatitis
急性胰腺炎后与糖尿病发展相关的临床、放射学和生化因素
  • 批准号:
    10264897
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
Clinical, Radiologic and Biochemical Factors Related to Diabetes Development after Acute Pancreatitis
急性胰腺炎后与糖尿病发展相关的临床、放射学和生化因素
  • 批准号:
    10670140
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
Clinical trial of an innovative digital therapeutic for smoking cessation with biochemical verification
具有生化验证的创新数字戒烟疗法的临床试验
  • 批准号:
    9557379
  • 财政年份:
    2018
  • 资助金额:
    $ 39.46万
  • 项目类别:
JPND GBA1 mutations in Parkinson disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.
JPND GBA1 帕金森病突变:临床和生化前驱症状、风险概况和治疗干预的发病机制模型。
  • 批准号:
    MR/N028651/1
  • 财政年份:
    2016
  • 资助金额:
    $ 39.46万
  • 项目类别:
    Research Grant
GBA1 mutations in Parkinson's disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.
帕金森病的 GBA1 突变:临床和生化前驱症状、风险概况和治疗干预的发病机制模型。
  • 批准号:
    332703
  • 财政年份:
    2015
  • 资助金额:
    $ 39.46万
  • 项目类别:
    Operating Grants
Analysis of effect of different treatment targets on maternal and child health outcomes in Gestational Diabetes Mellitus (GDM), review of specific treatments and development of clinical and biochemical predictors.
分析不同治疗目标对妊娠期糖尿病(GDM)母婴健康结局的影响,回顾具体治疗方法以及开发临床和生化预测因子。
  • 批准号:
    nhmrc : 1075932
  • 财政年份:
    2014
  • 资助金额:
    $ 39.46万
  • 项目类别:
    Postgraduate Scholarships
Clinical and Biochemical Predictors of Outcome after Knee Injury in Young Patient
年轻患者膝关节损伤后结果的临床和生化预测因素
  • 批准号:
    8847282
  • 财政年份:
    2012
  • 资助金额:
    $ 39.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了